Hawaii Senate approves wider access to medical cannabis

The Hawaii State Senate has approved a bill that significantly expands the state medical cannabis program, giving healthcare providers greater autonomy to recommend treatment.

By 24 to 1, lawmakers passed the HB 302 law, a provision that allows it to be prescribed for any medical condition deemed appropriate by a healthcare provider.

A major change in medical cannabis policy

Under current law, medical cannabis can only be recommended for a limited list of conditions approved by the state. House Bill 302, originally introduced by the Democratic Representative Gregg Takayama, proposed a broader interpretation of the eligibility criteria. However, after being amended by the Senate committees, the bill goes even further by eliminating the list entirely.

The updated bill redefines a « disabling medical condition »as «any condition determined by the certifying physician or registered nurse practitioner to be appropriate for the medical use of cannabis.» This change effectively shifts decision-making authority from regulators to healthcare professionals, resulting in more flexible access to medical cannabis.".

The bill also eliminates the requirement for the referring physician to conduct an initial in-person consultation with the patient, which further simplifies access.

Political support and strategic intent

The vote follows a political direction indicated by the Governor Josh Green, who has publicly advocated for broader access to cannabis. Last year, Mr. Green announced his intention to expand the Hawaii's medical cannabis program after the legislature failed to pass legislation legalizing the use of cannabis for adults.

«This would make marijuana widely available to those who choose to use it,» Mr. Green said in a previous interview, noting that the changes would continue to prioritize the safety of young people.

The governor also reiterated his position on full legalization: «I believe that adults who want to use marijuana responsibly should be able to do so.»

Bill HB 302 aligns with this vision, paving the way for greater access while avoiding the more controversial debate over full legalization.

The Department of Health raises concerns

Despite strong legislative and executive support, the Ministry of Health‘Hawaii’ expressed reservations about the scope of the bill.

In a written statement, the ministry acknowledged the value of allowing providers to exercise professional judgment, but cautioned: «There is little scientific evidence supporting the use of cannabis for conditions beyond those currently listed in the law.»

The Department of Health has expressed concerns about the patient safety, including the possibility of’adverse drug interactions between cannabis and other treatments. To address this, he recommended that only the patient’s healthcare provider be authorized to certify patients for unspecified conditions—a suggestion that lawmakers did not adopt.

The bill is now moving through the legislative process, with attention focused on how the state will implement these changes and address regulatory concerns.